AbbVie Inc. (ABBV) short interest & options flow
NYSEABBV is trading at $291.31, a week after one of the most concentrated bursts of analyst target-raising in its recent history, and the question now is whether the Street's enthusiasm can pull the stock through to the $320-340 range where the new consensus clusters. The post-earnings upgrade wave that defined last Monday's session has largely played out. Eight firms raised targets on…
ABBV cost to borrow jumped 113% over the past week to 0.51%, its highest level in a month as short interest retreats to a year low.
- Market cap
- $518.44B
- Next earnings
- 2 Feb 2027
Key data as of 10 Nov 2026
Latest signals on ABBV
- Cost to Borrow
ABBV cost to borrow jumped 113% over the past week to 0.51%, its highest level in a month as short interest retreats to a year low.
ABBV Stock Report — available now on ORTEX
A new long-form analysis for ABBV this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumABBV news and analysis
RSSNo long-form analysis yet for ABBV. Pulse alerts and the live data picture are available on ORTEX.
Open ABBV on ORTEX →Want the live picture for ABBV?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABBV — free to start on ORTEX.
Sign up for free →Open ABBV on ORTEX